Free Trial

Sotera Health (NASDAQ:SHC) Given Consensus Rating of "Moderate Buy" by Brokerages

Sotera Health logo with Medical background

Sotera Health (NASDAQ:SHC - Get Free Report) has earned an average rating of "Moderate Buy" from the seven analysts that are covering the company, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $16.08.

Several brokerages have weighed in on SHC. Royal Bank of Canada reiterated an "outperform" rating and issued a $17.00 price objective on shares of Sotera Health in a research note on Thursday, November 21st. The Goldman Sachs Group assumed coverage on Sotera Health in a research note on Friday. They issued a "neutral" rating and a $14.00 price target for the company. Finally, Citigroup raised their price objective on Sotera Health from $18.00 to $20.00 and gave the stock a "buy" rating in a research note on Wednesday, November 6th.

Read Our Latest Analysis on SHC

Sotera Health Stock Performance

Shares of NASDAQ:SHC traded up $0.17 during trading on Monday, reaching $13.30. 1,032,984 shares of the stock were exchanged, compared to its average volume of 1,342,599. Sotera Health has a 12 month low of $10.71 and a 12 month high of $17.44. The stock has a 50-day moving average price of $14.89 and a 200-day moving average price of $14.11. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. The firm has a market cap of $3.77 billion, a PE ratio of 53.92 and a beta of 1.96.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its quarterly earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.01). The firm had revenue of $285.47 million during the quarter, compared to the consensus estimate of $278.64 million. Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The business's revenue for the quarter was up 8.5% compared to the same quarter last year. During the same quarter last year, the firm earned $0.18 earnings per share. Research analysts expect that Sotera Health will post 0.61 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD grew its position in Sotera Health by 25.8% in the first quarter. Price T Rowe Associates Inc. MD now owns 59,480 shares of the company's stock valued at $715,000 after acquiring an additional 12,195 shares during the last quarter. Comerica Bank increased its position in Sotera Health by 20.1% during the 1st quarter. Comerica Bank now owns 48,179 shares of the company's stock worth $579,000 after purchasing an additional 8,074 shares in the last quarter. CWM LLC lifted its stake in Sotera Health by 86.1% in the 2nd quarter. CWM LLC now owns 2,146 shares of the company's stock valued at $25,000 after purchasing an additional 993 shares during the last quarter. Simplicity Wealth LLC acquired a new stake in Sotera Health in the second quarter valued at approximately $128,000. Finally, Wedmont Private Capital bought a new stake in shares of Sotera Health during the second quarter worth $127,000. 91.03% of the stock is currently owned by institutional investors and hedge funds.

About Sotera Health

(Get Free Report

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.

Featured Stories

Analyst Recommendations for Sotera Health (NASDAQ:SHC)

Should you invest $1,000 in Sotera Health right now?

Before you consider Sotera Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sotera Health wasn't on the list.

While Sotera Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Future of Healthcare: 3 AI Stocks Leading the Way
Analysts Predict Big Gains for These 3 Cybersecurity Leaders
This Investment Strategy Has the Highest Payout Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines